Detalhe da pesquisa
1.
Personalizing health care: feasibility and future implications.
BMC Med
; 11: 179, 2013 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23941275
2.
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications.
Expert Rev Pharmacoecon Outcomes Res
; 21(4): 527-540, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33535841
3.
Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries.
Front Pharmacol
; 11: 845, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32581804
4.
Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA.
Expert Rev Pharmacoecon Outcomes Res
; 19(3): 251-261, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30696372
5.
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets.
Front Public Health
; 6: 328, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30568938
6.
Drug Policy in Slovakia.
Value Health Reg Issues
; 13: 44-49, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29073987
7.
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications.
Pharmacoeconomics
; 35(12): 1271-1285, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28836222
8.
Health care reform in six Central European countries. A focus on health economic requirements in the drug pricing and reimbursement processes.
Eur J Health Econ
; 4(4): 286-91, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15609197
9.
Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs.
Front Pharmacol
; 5: 109, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24959145
10.
Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.
Front Pharmacol
; 4: 39, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23717279
11.
Trends in the lung cancer incidence and mortality in the Slovak and Czech Republics in the contexts of an international comparison.
Clin Transl Oncol
; 14(9): 659-66, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22855145